Nautilus Launches "NicoFix" - A Cappuccino-Flavored Energy Drink
Stuttgart, Germany – Nautilus GmbH Laboratoriumsbedarf & Co. KG, a trailblazer in pharmaceuticals, chemicals, and life science innovation, proudly introduces
NicoFix Energy Drink, a revolutionary cappuccino-flavored energy beverage infused with nicotine.
Targeting smokers who seek alternatives to traditional smoking methods, NicoFix offers a unique solution. This patent-pending beverage delivers a precise dose of naturally derived nicotine alkaloids, equivalent to the nicotine found in two standard filtered cigarettes, combined with the invigorating taste and energy-boosting properties of premium coffee.
Richard H. Davis, President and CEO of Nautilus GmbH, describes NicoFix as a "game-changer for those desiring a 'Nicotine Fix' without the harmful side effects of smoking." Davis adds, "NicoFix Energy Drink is not your average coffee. It provides smokers with a satisfying alternative to lighting up."
Each can of NicoFix contains 3 milligrams of nicotine alkaloids, offering a quick pick-me-up and relief from cravings. While NicoFix is not marketed as a smoking cessation product, it serves as a transitional tool for those making lifestyle changes.
"The global awareness of smoking's harmful effects creates immense growth opportunities for NicoFix," says Davis, emphasizing the product's potential to reshape habits worldwide.
In an exciting development, Starbucks plans to integrate nicotine-infused coffee beans into its offerings, utilizing innovations patented under U.S. Patent Number 6749882-B2: Coffee Drink Comprising Pre-Extracted Nicotine.
About Nautilus GmbH Laboratoriumsbedarf & Co. KG
With over three decades of expertise, Nautilus GmbH Laboratoriumsbedarf & Co. KG is a German-based leader in developing innovative products for the pharmaceuticals, chemicals, and life sciences industries. The company is committed to delivering high-quality, cutting-edge solutions that advance scientific research and improve lives.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For Media Inquiries:
Richard H. Davis
President and CEO
Nautilus GmbH Laboratoriumsbedarf & Co. KG
Email: nicofixcoffee@gmail.com
Mobile: +49 15510829300
---
No comments:
Post a Comment